Skip to content
healthcare.dev

LECANEMAB AUTOINJECTOR

NDC 62856-222, lecanemab-irmb, injection, solution, from Eisai Inc..

Product NDC
62856-222
Status
Listed
Labeler
Eisai Inc.
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761375
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62856-222 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LECANEMAB-IRMB200 mg/mL

Pharmacologic classes

Amyloid Beta-directed Antibody Interactions [MoA]; Amyloid Beta-directed Antibody [EPC]

Package NDCNDC-11Package
62856-222-02628560222022 SYRINGE, PLASTIC in 1 CARTON (62856-222-02) / 1.25 mL in 1 SYRINGE, PLASTIC (62856-222-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9d1ff786-e577-410a-a273-c4d7d0e4e975

Use it

Look up 62856-222 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62856-222 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62856-222. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.